NWMP
NVS icon

Noble Wealth Management PBC’s Novartis NVS Stock Holding History

Noble Wealth Management PBC’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25K Buy
+8
New +$1.2K ﹤0.01% 664

Other funds holding NVS

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
GGI
Godsey & Gibb Inc Richmond, Virginia $1.22B AUM 27.93% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
MIM
Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return

Noble Wealth Management PBC's NVS Position: Q2 2026 in Review

Noble Wealth Management PBC opened a new position in Novartis (NVS) in Q2 2026: 8 shares worth $1.25K. The stake represents ﹤0.01% of the portfolio and ranks #664 among its holdings.

605 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Noble Wealth Management PBC held 8 shares of Novartis worth $1.25K as of Q2 2026.
  • Novartis was a new Noble Wealth Management PBC position in Q2 2026.
  • Novartis made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q2 2026, its #664 holding.
  • 605 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Noble Wealth Management PBC's 13F filing for Q2 2026, filed 1 Jul 2026.